electroCore, Inc. (NASDAQ:ECOR – Get Free Report) CFO Joshua Lev sold 12,000 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $10.22, for a total value of $122,640.00. Following the completion of the transaction, the chief financial officer owned 84,889 shares of the company’s stock, valued at $867,565.58. This trade represents a 12.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
electroCore Price Performance
Shares of NASDAQ ECOR traded down $0.18 during mid-day trading on Tuesday, reaching $9.47. 109,294 shares of the company’s stock were exchanged, compared to its average volume of 88,973. The firm has a market capitalization of $85.42 million, a price-to-earnings ratio of -5.70 and a beta of 0.93. electroCore, Inc. has a 52 week low of $4.41 and a 52 week high of $10.95. The firm has a 50-day moving average price of $7.74 and a two-hundred day moving average price of $7.21.
electroCore (NASDAQ:ECOR – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.42) by $0.09. electroCore had a negative net margin of 39.96% and a negative return on equity of 1,956.38%. The company had revenue of $9.45 million during the quarter, compared to analyst estimates of $9.49 million. As a group, sell-side analysts forecast that electroCore, Inc. will post -1.4 EPS for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Analysis on electroCore
Institutional Investors Weigh In On electroCore
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ECOR. Cubist Systematic Strategies LLC bought a new position in electroCore during the first quarter worth about $153,000. Two Sigma Investments LP raised its position in shares of electroCore by 20.8% in the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after purchasing an additional 4,231 shares during the period. WealthShield Partners LLC purchased a new stake in shares of electroCore during the 1st quarter valued at approximately $157,000. Jane Street Group LLC lifted its stake in shares of electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after buying an additional 19,599 shares in the last quarter. Finally, DRW Securities LLC bought a new position in electroCore in the 4th quarter worth approximately $264,000. 26.74% of the stock is currently owned by institutional investors.
About electroCore
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Read More
- Five stocks we like better than electroCore
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
